Oncologie nieuws
- Breakthrough research extends hope for gastric cancer patients with peritoneal metasis
- Sex matters in how, when, and where melanomas develop, study finds
- Fertility-Sparing treatment in MSI-H/MMRd endometrial carcinoma or atypical endometrial Hyperplasia: A systematic review and Meta-Analysis
- FDA Approves Daratumumab and Hyaluronidase-fihj with Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
- Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update
- Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
- Extending inflamed-class signature to predict immune checkpoint inhibitor-based combination therapy in hepatocellular carcinoma
- Real-world trends in the use of maintenance therapy in ovarian cancer across the United States from 2017 to 2021
- Potential diagnostic and prognostic biomarkers of pediatric Burkitt lymphoma identified through miRNA expression profiling
- Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma
- A new digital droplet PCR method for looking at epigenetics in diffuse large B?cell lymphomas: The role of BMI1, EZH2, and USP22 genes
- Whole Lung Irradiation in Rhabdomyosarcoma With Lung Metastases: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group
- Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma
- Exosomal miR-155-5p drives ibrutinib resistance in B-cell lymphoma
- Application of linaclotide in bowel preparation for colonoscopy in patients with constipation: A prospective randomized controlled study